ProMab Biotechnologies retweeted
Scientists deciphered functional diversification and dynamics of peripheral CAR-T cells post-infusion in this @CellReports study.
🔎 Discover their findings: shorturl.at/agtZ6
ProMab Biotechnologies retweeted
Anyone can create a logo using AI.
Microsoft offers a free tool to do it quickly.
Here's how to create your logo (and vectorize it):
ProMab Biotechnologies retweeted
This is GPT-4 Week 6, you won't believe what AI can do now.
Here are 10 new AI developments making it yet another crazy week: 👇
ProMab Biotechnologies retweeted
The approval of ipilimumab: a first 1st for cancer #immunotherapy: “For all of us, this was a monumental event.” – Jedd Wolchok @wolchokj , PICI director at @sloan_kettering, with Jim Allison, Alan Korman and PICI CEO Jeff Bluestone at #AACR19 history of CTLA-4 session
ProMab Biotechnologies retweeted
Breaks my heart. This sweet Texas boy needs a bone marrow donor to save his life. Are you a marrow donor? Have you been tested? Please share Ayden's story. Maybe social media can do some good and help save this 6 year old's life. mol.im/a/6691871
ProMab Biotechnologies retweeted
The immunotherapy Daily is out! paper.li/f-1462097664?editio… Stories via @BeyondCeliac @SamWLee1 @MendedHearts #mhealth #digitalhealth
ProMab Biotechnologies retweeted
Coming soon from the Paulos lab:
CAR T cells in solid tumors: blueprints for building effective therapies frontiersin.org/articles/10.… – at South Carolina, USA
ProMab Biotechnologies retweeted
The immunotherapy Daily is out! paper.li/f-1462097664?editio… Stories via @MelanomaReAlli @BCRFcure @equitiesinc #mhealth #digitalhealth
ProMab Biotechnologies retweeted
As a survivor of #CARTcell for #Novartis clinical trial before FDA approval... This is music to my ears! 🧡 nitter.cf/vasnarasimhan/status/9… – at Jenkintown, PA
Thrilled @US_FDA have approved of our #CARTcell therapy in a 2nd indication. This provides a new option and hope to cancer patients who are in critical need of treatment. Very proud of the @NovartisCancer team’s hard work to bring it to reality. nitter.cf/Novartis/status/991418…
ProMab Biotechnologies retweeted
Bigger picture study casts big doubts on #stemcells for knee arthritis today via @pknoepfler & the CIRM Stem Cellar. https://nitter.cf/t.co/tmq81Y14dC
ProMab Biotechnologies retweeted
ProMab Biotechnologies retweeted
Target all solid cancers, no CD47 req'd. Computing power meets immunotherapy
clinicaltrials.gov/ct2/show/…
ProMab Biotechnologies retweeted
Concise Review: Human Pluripotent Stem Cells to Produce Cell-Based Cancer Immunotherapies. #StemCells #Cancer #Immunotherapy onlinelibrary.wiley.com/doi/…
ProMab Biotechnologies retweeted
.@UCLAHealth researchers recreate germ cell tumors from #stemcells. Will help lead to better understanding of pediatric #cancers. https://nitter.cf/t.co/L30aoF8EKM via @ELSStemCell
ProMab Biotechnologies retweeted
And CAR #TCell poster kid Emily Whitehead on cover of course #icon @EWhiteheadFdn nitter.cf/EricTopol/status/95728…
How do you know when CAR-T cell therapy for #cancer has hit it big?
When it's the feature @readersdigest
ProMab Biotechnologies retweeted
The immunotherapy Daily is out! paper.li/f-1462097664?editio… Stories via @NADF_President @LaLecheLeagueUS @ReeseAStephens #mhealth #digitalhealth
ProMab Biotechnologies retweeted
How to refer your patients for our specialized #cancer care: https://nitter.cf/t.co/Fs72hJXkWu #endcancer
ProMab Biotechnologies retweeted
CAR T-Cells: Promise and Peril of Cancer’s Silver Bullet – UNIT SCIENTIFIC nicolegularte.wordpress.com/…
ProMab Biotechnologies retweeted
I am a cancer survivor because of an amazing team @PennMedicine Go #Kymriah Go #Tmunity Go #CellTherapy philly.com/philly/blogs/inq-…
ProMab Biotechnologies retweeted
Why can’t the broader health care industry agree on how to make drugs more affordable? Here are five factors. buff.ly/2neeWMN


























